Try our Advanced Search for more refined results
Purdue Pharma L.P.
Case Number:
7:19-bk-23649
Court:
Nature of Suit:
Firms
- Teitelbaum Law Group
- Binder & Schwartz
- Consovoy McCarthy
- MoloLamken
- Faegre Drinker
- Klehr Harrison
- Sherrard Roe
- Porzio Bromberg
- Reed Smith
- Frost Brown
- Godfrey & Kahn
- Himes Petrarca
- Alston & Bird
- Lowe Stein
- Terrell Hogan
- Taft Stettinius
- Quinn Emanuel
- UB Greensfelder
- Dechert LLP
- Blank Rome
- Spangenberg Shibley
- Potter Anderson
- Cleary Gottlieb
- Duane Morris
- Clifford Law Offices
- Gage Spencer & Fleming
- McElroy Deutsch
- Goodwin Procter
- Motley Rice
- Phillips Lytle
- Gertz & Rosen
- WilmerHale
- Andrews & Thornton
- Dentons
- Joseph Hage Aaronson
- ASK LLP
- Cuneo Gilbert
- Katsky Korins
- Pillsbury Winthrop
- Lite DePalma
- WestLoop Law
- Pashman Stein
- Slevin & Hart
- Cronin Fried
- Gilbert LLP
- Mehri & Skalet
- Squire Patton
- McGrail & Bensinger
- Bentley & Bruning
- Miller Shah LLP
- Pachulski Stang
- Lerner Arnold
- Kramer Levin
- Bialson Bergen
- King & Spalding
- Bielli & Klauder
- ArentFox Schiff LLP
- Martin S. Rapaport
- Schulte Roth
- Blitman & King
- Saul Ewing
- Wilk Auslander
- Stutzman Bromberg
- Debevoise & Plimpton
- Shipman & Goodwin
- Simpson Thacher & Bartlett LLP
- Caplin & Drysdale
- Porter Hedges
- Brown & Connery
- Hagens Berman
- Marino Tortorella
- Napoli Shkolnik
- Robins Kaplan
- Marcus & Shapira
- Doster Ullom
- Simmons Hanly
- Mintz Levin
- Shafferman & Feldman
- Hughes Socol
- Davis Polk
- O'Melveny & Myers
- Brown Rudnick
- Barack Ferrazzano
- Kleinberg Kaplan
- Burke Warren
- Levenfeld Pearlstein
- Rothstein Mandell
- O'Brien Belland
- BatesCarey
- MacElree Harvey
- Keller Rohrback
- Carter Ledyard
- Hurwitz Fine
- Miller Nash LLP
- Keller Postman
- Pullman & Comley
- Loeb & Loeb
- Foley & Lardner
- Seyfarth Shaw
- Skadden Arps
- Troutman
- Shook Hardy
- Morgan Lewis
- Arnold & Porter
- Tarter Krinsky
- Tate Law Group LLC
- Jones Day
- Kirkland & Ellis
- Lowey Dannenberg
- Stevens & Lee
- Williams Mullen
- Porteous Hainkel
- Kobre & Kim
- Akin Gump
- Wachtell Lipton
- Waldrep Wall
- Ifrah Law
- Seward & Kissel
- Crowell & Moring
- Ballard Spahr
- ArentFox Schiff
- White Coleman & Associates
- Henrichsen Law Group
- Jenner & Block
- Haug Partners
- Hobbs Straus
- Latham & Watkins
- Mayer Brown
- White & Case
- Willkie Farr
Companies
- Teamsters Local 456
- AXA XL Ltd.
- Impax Laboratories, Inc.
- Henry Schein Inc.
- Sun Pharmaceutical Industries Ltd.
- Hikma Pharmaceuticals PLC
- Houlihan Lokey Inc.
- Province LLC
- Sandoz International GmbH
- Kodiak Area Native Association
- Ranbaxy
- PRA Health Sciences Inc.
- Johnson & Johnson
- Aleutian Pribilof Islands Association Inc.
- Collegium Pharmaceutical Inc.
- Omnicare Inc.
- Endo International PLC
- Tucson Medical Center
- United Parcel Service Inc.
- Anda Inc.
- Avrio Health LP
- Hain Capital Group LLC
- KVK Tech Inc.
- Amneal Pharmaceuticals Inc.
- TR Capital Management LLC
- Ironshore Inc.
- Express Scripts Holding Co.
- The Cigna Group
- Walmart Inc.
- Noramco Inc.
- FTI Consulting Inc.
- Alaska Native Tribal Health Consortium
- Viatris Inc.
- DuPont de Nemours Inc.
- Allergan PLC
- Old Republic Insurance Co.
- Purdue Pharma LP
- United Food & Commercial Workers International Union
- Bausch Health Cos. Inc.
- ASM Capital LP
- SAP AG
- Apria Healthcare Group
- Cardinal Health Inc.
- CVS Health Corp.
- Liberty Mutual Insurance Group
- Bristol-Myers Squibb Co.
- AlixPartners LLP
- McKesson Corp.
- Nardello & Co. LLC
- Arcadia Consumer Healthcare
- International Union Of Operating Engineers
- Otis Worldwide Corp.
- Blue Cross Blue Shield Association
- Cencora Inc.
- Loblaw Cos.
- Oracle Corp.
- Giant Eagle Inc.
- Thermo Fisher Scientific Inc.
- Verita Global LLC
- American Federation of Labor & Congress of Industrial Organizations
- Jefferies Financial Group Inc.
- Teva Pharmaceutical Industries Ltd.
Government Agencies
- Seldovia Village Tribe
- Missouri Department of Revenue
- U.S. District Court for the District of Columbia
- Pala Band of Mission Indians
- State of Nevada
- Town of Ramapo, New York
- Pension Benefit Guaranty Corp.
- City of Bayonne, New Jersey
- Washington State Department of Revenue
- New York Department of Financial Services
- Port Gamble S'Klallam Tribe
- Nez Perce Tribe
- Borough of Paramus, New Jersey
- Jamestown S'Klallam Tribe
- Northwestern Band of the Shoshone Nation
- Commonwealth of Massachusetts
- Town of Babylon, New York
- Town of Brookhaven, New York
- Town of Hempstead, New York
- Hopi Tribe
- St. Regis Mohawk Tribe
- Tennessee Attorney General's Office
- Suquamish Tribe
- State of Indiana
- Ohio Attorney General's Office
Sectors & Industries:
-
March 03, 2022
Purdue Reaches Final Terms On New $5.5B Ch. 11 Settlement
The mediator running negotiations between bankrupt drugmaker Purdue Pharma LP and the nine states that opposed its vacated Chapter 11 plan said Thursday the sides have reached a new deal that will see contributions from the Sackler family members who own the debtor increase to at least $5.5 billion.
-
March 02, 2022
Purdue Mediator Extends Talks To Work On Deal Terms
The mediator overseeing negotiations for a new Purdue Pharma restructuring plan Wednesday told a New York bankruptcy judge she is extending the talks, citing her authority to take more time if she's involved in drafting terms for a deal.
-
February 18, 2022
Sacklers Offer Another $1.6B For Purdue Ch. 11 Settlement
The mediator overseeing negotiations for a new Chapter 11 plan for Purdue Pharma reported Friday that the drugmaker's former owners in the Sackler family have agreed to add more than $1.6 billion to the $4.3 billion settlement they would have paid under the company's prior, scuttled bankruptcy plan.
-
February 17, 2022
Purdue Gets OK For 2-Week Opioid Suit Freeze Extension
A New York bankruptcy judge Thursday gave Purdue Pharma a two-week extension on an injunction pausing litigation against the company after being told the drugmaker is closing in on an agreement for a new Chapter 11 plan.
-
February 09, 2022
NY Judge OKs Canadian Entities' Late Purdue Ch. 11 Appeal
A New York federal judge on Wednesday approved a belated appeal filed by Canadian entities challenging Purdue Pharma's Chapter 11 plan, hours after Purdue said it had no problem with the appeal going forward before the Second Circuit.
-
February 08, 2022
Canadian Entities Seek Late Appeal In Purdue Ch. 11 Case
Canadian entities are seeking permission to file a late appeal to a New York federal court ruling that vacated Purdue Pharma's Chapter 11 plan, saying Tuesday there are unresolved issues related to their claims that won't be covered by the drugmaker's challenge in the Second Circuit.
-
February 04, 2022
Purdue Asks For New Extension On Opioid Suit Freeze
Purdue Pharma has asked a New York bankruptcy judge for another extension on the opioid litigation injunction that has been in place since it filed for bankruptcy, citing word that a settlement agreement is near on a modified reorganization plan and the considerable work that would follow.
-
February 01, 2022
Purdue Closing In On New Ch. 11 Deal With Sackler Family
A New York bankruptcy judge extended a mediation deadline Tuesday in the Chapter 11 case of Purdue Pharma after the mediator reported the parties were close to a deal that would see members of the Sackler family significantly increase their more than $4.3 billion in payments under the debtor's scuttled plan.
-
January 03, 2022
A Blockbuster Year Ahead For Health, Life Sciences Litigation
Health care and life sciences litigation is already red hot as 2022 begins and appears all but certain to intensify throughout the year as the clock ticks on time-sensitive lawsuits, the U.S. Supreme Court nears the end of its current term and opioid cases generate more trials and fresh drama. Here, Law360 explores five key litigation areas to watch.
-
December 06, 2021
Sackler Family Denies Pre-Ch. 11 Looting Of Purdue Pharma
Members of the Sackler family who own drugmaker Purdue Pharma told a New York federal judge Monday that they did not increase transfers of cash out of the business in the run-up to its 2019 Chapter 11 filing, and instead left the company with more unrestricted cash than ever before at that time.